Oncology
Restoring tumor suppressor genes
Our technologies can be applied to the development of new genetic medicines that can help to treat oncological targets.
We have the potential to restore specific genes that are involved in oncology. In many cancer forms tumor suppressors (e.g. TP53) have become ineffective. Our technology can be used to restore tumor suppressor functionality and could be used in combination with other cancer treatments to further enhance the combined effectiveness.